BLUECAUTIOUS

BLUE Gross Margin Analysis

68.4%

Higher than 52% of Healthcare sector peers

Updated 2556h ago·SEC filings & market data

Key Takeaway

Gross margin represents the percentage of revenue a company retains after paying for the direct costs of producing its goods or services; bluebird bio's current 68.4% means that for every dollar of revenue, about 68 cents is left to cover other expenses and profit.

Sector Performance

52th percentile

BLUE

68.4%

Sector Median

68.3%

Sector Avg

-55.4%

📊

Deep Analysis

Gross margin represents the percentage of revenue a company retains after paying for the direct costs of producing its goods or services; bluebird bio's current 68.4% means that for every dollar of revenue, about 68 cents is left to cover other expenses and profit.

This figure sits slightly below the healthcare sector median of 69.4%, placing the company in the 48th percentile among its peers—essentially middle-of-the-pack for profitability from its core product sales. The trend data is not available, with both the year-over-year and quarter-over-quarter changes listed as "N/A," so there is no historical direction to assess improvement or deterioration. Because the gross margin is moderately high and roughly in line with the sector median, the lack of trend information introduces uncertainty about stability, making it hard to gauge whether this level is sustainable or a temporary snapshot. This metric neither signals a clear strength nor a weakness, which aligns with the overall NEUTRAL verdict: the gross margin is adequate but unremarkable, contributing no strong reason to lean bullish or bearish at this point.

Frequently Asked Questions

What does the Gross Margin tell investors about BLUE?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

How does BLUE's Gross Margin compare to its sector?

BLUE's Gross Margin of 68.4% compares to a Healthcare sector median of 68.3%, placing it in the 52th percentile.

Who are BLUE's closest peers by Gross Margin?

The closest Healthcare peers by Gross Margin include: AMGN (68.2%), TECH (66.9%), EXAS (70.1%), ALGN (70.8%), RHHBY (71.7%).

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

Advertisement

Master BLUE's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full BLUE research report

Free account — no credit card

BLUE

68.4%

Sector Median

68.3%

Sector Avg

-55.4%

How BLUE's Gross Margin compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.